Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)

Todd P. McCarty, John W. Baddley, Thomas J. Walsh, Barbara D. Alexander, Dimitrios P. Kontoyiannis, Trish M. Perl, Randall Walker, Thomas F. Patterson, Mindy G. Schuster, G. M. Lyon, John R. Wingard, David R. Andes, Benjamin J. Park, Mary E. Brandt, Peter G. Pappas

Research output: Contribution to journalArticle

Abstract

Transplant recipients are at a high risk for developing invasive fungal infections. The agents of phaeohyphomycosis are environmental molds found worldwide, and they cause a broad spectrum of disease including skin and subcutaneous lesions, pneumonia, central nervous system disease, fungemia, and disseminated disease. Using data from the Transplant Associated Infection Surveillance Network (TRANSNET), we evaluated patients with proven and probable phaeohyphomycosis. Centers collected data on demographics, co-morbid conditions, clinical features, treatment, and three-month mortality. Fifty-six patients with phaeohyphomycosis were identified from 15 centers, comprising 26 stem cell transplant (SCT) and 30 solid organ transplant (SOT) recipients. Median time to diagnosis post-transplant was 358 days (SCT 100 days; SOT 685 days; P =

Original languageEnglish (US)
Pages (from-to)440-446
Number of pages7
JournalMedical Mycology
Volume53
Issue number5
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Phaeohyphomycosis
organ transplantation
stem cells
Transplants
central nervous system diseases
monitoring
skin diseases
Infection
infection
molds (fungi)
pneumonia
demographic statistics
Stem Cells
Fungemia
Central Nervous System Diseases
Skin Diseases
Transplant Recipients
Pneumonia
Fungi
Demography

Keywords

  • Alternaria
  • Dematiaceous mold
  • Exserohilum
  • Phaeohyphomycosis

ASJC Scopus subject areas

  • veterinary(all)
  • Infectious Diseases

Cite this

McCarty, T. P., Baddley, J. W., Walsh, T. J., Alexander, B. D., Kontoyiannis, D. P., Perl, T. M., ... Pappas, P. G. (2015). Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Medical Mycology, 53(5), 440-446. https://doi.org/10.1093/mmy/myv018

Phaeohyphomycosis in transplant recipients : Results from the Transplant Associated Infection Surveillance Network (TRANSNET). / McCarty, Todd P.; Baddley, John W.; Walsh, Thomas J.; Alexander, Barbara D.; Kontoyiannis, Dimitrios P.; Perl, Trish M.; Walker, Randall; Patterson, Thomas F.; Schuster, Mindy G.; Lyon, G. M.; Wingard, John R.; Andes, David R.; Park, Benjamin J.; Brandt, Mary E.; Pappas, Peter G.

In: Medical Mycology, Vol. 53, No. 5, 2015, p. 440-446.

Research output: Contribution to journalArticle

McCarty, TP, Baddley, JW, Walsh, TJ, Alexander, BD, Kontoyiannis, DP, Perl, TM, Walker, R, Patterson, TF, Schuster, MG, Lyon, GM, Wingard, JR, Andes, DR, Park, BJ, Brandt, ME & Pappas, PG 2015, 'Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)', Medical Mycology, vol. 53, no. 5, pp. 440-446. https://doi.org/10.1093/mmy/myv018
McCarty, Todd P. ; Baddley, John W. ; Walsh, Thomas J. ; Alexander, Barbara D. ; Kontoyiannis, Dimitrios P. ; Perl, Trish M. ; Walker, Randall ; Patterson, Thomas F. ; Schuster, Mindy G. ; Lyon, G. M. ; Wingard, John R. ; Andes, David R. ; Park, Benjamin J. ; Brandt, Mary E. ; Pappas, Peter G. / Phaeohyphomycosis in transplant recipients : Results from the Transplant Associated Infection Surveillance Network (TRANSNET). In: Medical Mycology. 2015 ; Vol. 53, No. 5. pp. 440-446.
@article{8d55340e70d042088fff85bad49a54d7,
title = "Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)",
abstract = "Transplant recipients are at a high risk for developing invasive fungal infections. The agents of phaeohyphomycosis are environmental molds found worldwide, and they cause a broad spectrum of disease including skin and subcutaneous lesions, pneumonia, central nervous system disease, fungemia, and disseminated disease. Using data from the Transplant Associated Infection Surveillance Network (TRANSNET), we evaluated patients with proven and probable phaeohyphomycosis. Centers collected data on demographics, co-morbid conditions, clinical features, treatment, and three-month mortality. Fifty-six patients with phaeohyphomycosis were identified from 15 centers, comprising 26 stem cell transplant (SCT) and 30 solid organ transplant (SOT) recipients. Median time to diagnosis post-transplant was 358 days (SCT 100 days; SOT 685 days; P =",
keywords = "Alternaria, Dematiaceous mold, Exserohilum, Phaeohyphomycosis",
author = "McCarty, {Todd P.} and Baddley, {John W.} and Walsh, {Thomas J.} and Alexander, {Barbara D.} and Kontoyiannis, {Dimitrios P.} and Perl, {Trish M.} and Randall Walker and Patterson, {Thomas F.} and Schuster, {Mindy G.} and Lyon, {G. M.} and Wingard, {John R.} and Andes, {David R.} and Park, {Benjamin J.} and Brandt, {Mary E.} and Pappas, {Peter G.}",
year = "2015",
doi = "10.1093/mmy/myv018",
language = "English (US)",
volume = "53",
pages = "440--446",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Phaeohyphomycosis in transplant recipients

T2 - Results from the Transplant Associated Infection Surveillance Network (TRANSNET)

AU - McCarty, Todd P.

AU - Baddley, John W.

AU - Walsh, Thomas J.

AU - Alexander, Barbara D.

AU - Kontoyiannis, Dimitrios P.

AU - Perl, Trish M.

AU - Walker, Randall

AU - Patterson, Thomas F.

AU - Schuster, Mindy G.

AU - Lyon, G. M.

AU - Wingard, John R.

AU - Andes, David R.

AU - Park, Benjamin J.

AU - Brandt, Mary E.

AU - Pappas, Peter G.

PY - 2015

Y1 - 2015

N2 - Transplant recipients are at a high risk for developing invasive fungal infections. The agents of phaeohyphomycosis are environmental molds found worldwide, and they cause a broad spectrum of disease including skin and subcutaneous lesions, pneumonia, central nervous system disease, fungemia, and disseminated disease. Using data from the Transplant Associated Infection Surveillance Network (TRANSNET), we evaluated patients with proven and probable phaeohyphomycosis. Centers collected data on demographics, co-morbid conditions, clinical features, treatment, and three-month mortality. Fifty-six patients with phaeohyphomycosis were identified from 15 centers, comprising 26 stem cell transplant (SCT) and 30 solid organ transplant (SOT) recipients. Median time to diagnosis post-transplant was 358 days (SCT 100 days; SOT 685 days; P =

AB - Transplant recipients are at a high risk for developing invasive fungal infections. The agents of phaeohyphomycosis are environmental molds found worldwide, and they cause a broad spectrum of disease including skin and subcutaneous lesions, pneumonia, central nervous system disease, fungemia, and disseminated disease. Using data from the Transplant Associated Infection Surveillance Network (TRANSNET), we evaluated patients with proven and probable phaeohyphomycosis. Centers collected data on demographics, co-morbid conditions, clinical features, treatment, and three-month mortality. Fifty-six patients with phaeohyphomycosis were identified from 15 centers, comprising 26 stem cell transplant (SCT) and 30 solid organ transplant (SOT) recipients. Median time to diagnosis post-transplant was 358 days (SCT 100 days; SOT 685 days; P =

KW - Alternaria

KW - Dematiaceous mold

KW - Exserohilum

KW - Phaeohyphomycosis

UR - http://www.scopus.com/inward/record.url?scp=84942082144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942082144&partnerID=8YFLogxK

U2 - 10.1093/mmy/myv018

DO - 10.1093/mmy/myv018

M3 - Article

C2 - 25908651

AN - SCOPUS:84942082144

VL - 53

SP - 440

EP - 446

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

IS - 5

ER -